SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
Article in BMC Medical Genomics (April 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in BMC Medical Genomics (April 2024)
Article in Archives of Oral Biology (April 2024)
Article in European Journal of Medical Research (April 2024)